A berry compound, already shown to have cancer-fighting properties, may be as effective as a widely used synthetic drug in reducing lipids, according to a study on rats.
The compound pterostilbene has the potential to be developed into a nutraceutical for lowering cholesterol, particularly for those who do not respond well to conventional drugs used for this purpose, say the researchers.








